Oxford, MS ― November 18, 2011 ― Brian Reisetter and Doug Paul, vice presidents and partners at Medical Marketing Economics, have published an article on the budget impact of biosimilars in Pharmacy Purchasing & Products. “Projecting the Budget Impact of Biosimilars” appears in the November 2011 issue of the journal.
The complete article is available at the PP&P site.
For more information about PP&P as well as additional articles of interest, see the journal’s homepage.
For additional information about Brian Reisetter, Doug Paul, or Medical Marketing Economics, please contact us at 662.281.0502 or via e-mail at info@m2econ.com.
